Cargando…
Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade
OBJECTIVES: The population of adults with congenital heart defects (ACHD) is continuously growing. Data on morbidity and mortality of ACHD are limited. This longitudinal observational study examined a group of ACHD with surgically corrected or palliated congenital heart defects (CHD) during a 15-yea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334441/ https://www.ncbi.nlm.nih.gov/pubmed/35229166 http://dx.doi.org/10.1007/s00392-022-01989-1 |
_version_ | 1784759106274328576 |
---|---|
author | Müller, Matthias J. Norozi, Kambiz Caroline, Jonas Sedlak, Nicole Bock, Jonas Paul, Thomas Geyer, Siegfried Dellas, Claudia |
author_facet | Müller, Matthias J. Norozi, Kambiz Caroline, Jonas Sedlak, Nicole Bock, Jonas Paul, Thomas Geyer, Siegfried Dellas, Claudia |
author_sort | Müller, Matthias J. |
collection | PubMed |
description | OBJECTIVES: The population of adults with congenital heart defects (ACHD) is continuously growing. Data on morbidity and mortality of ACHD are limited. This longitudinal observational study examined a group of ACHD with surgically corrected or palliated congenital heart defects (CHD) during a 15-year period. METHODS: ACHD that had participated in the initial study were invited for a follow-up examination. Mortality and hospitalization data were compared with a healthy control group. RESULTS: From 05/2017 to 04/2019 a total of 249/364 (68%) ACHD participated in the follow-up study: 21% had mild, 60% moderate and 19% severe CHD. During the observational period, 290 health incidents occurred (cardiac catheterization 37%, cardiovascular surgery 27%, electrophysiological study/ablation 20%, catheter interventional treatment 14%, non-cardiac surgery 3%). Events were more frequent in ACHD with moderate (53%) and severe (87%) compared to those with mild CHD (p < 0.001). 24 individuals died at a median age of 43 years during the observation period. 29% of them had moderate and 71% severe CHD corresponding to a mortality rate of 0%, 0.29% and 1.68% per patient-year in ACHD with mild, moderate and severe CHD. Long-term survival was significantly reduced in patients with severe CHD in comparison to individuals with mild and moderate CHD (p < 0.001). CONCLUSION: After correction or palliation of CHD, there was remarkable ongoing morbidity and mortality in ACHD patients over the 15-year observation period, particularly in individuals with moderate and severe CHD when compared with the general population. Thus, life-long special care is required for all surgically corrected or palliated ACHD patients. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9334441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-93344412022-07-30 Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade Müller, Matthias J. Norozi, Kambiz Caroline, Jonas Sedlak, Nicole Bock, Jonas Paul, Thomas Geyer, Siegfried Dellas, Claudia Clin Res Cardiol Original Paper OBJECTIVES: The population of adults with congenital heart defects (ACHD) is continuously growing. Data on morbidity and mortality of ACHD are limited. This longitudinal observational study examined a group of ACHD with surgically corrected or palliated congenital heart defects (CHD) during a 15-year period. METHODS: ACHD that had participated in the initial study were invited for a follow-up examination. Mortality and hospitalization data were compared with a healthy control group. RESULTS: From 05/2017 to 04/2019 a total of 249/364 (68%) ACHD participated in the follow-up study: 21% had mild, 60% moderate and 19% severe CHD. During the observational period, 290 health incidents occurred (cardiac catheterization 37%, cardiovascular surgery 27%, electrophysiological study/ablation 20%, catheter interventional treatment 14%, non-cardiac surgery 3%). Events were more frequent in ACHD with moderate (53%) and severe (87%) compared to those with mild CHD (p < 0.001). 24 individuals died at a median age of 43 years during the observation period. 29% of them had moderate and 71% severe CHD corresponding to a mortality rate of 0%, 0.29% and 1.68% per patient-year in ACHD with mild, moderate and severe CHD. Long-term survival was significantly reduced in patients with severe CHD in comparison to individuals with mild and moderate CHD (p < 0.001). CONCLUSION: After correction or palliation of CHD, there was remarkable ongoing morbidity and mortality in ACHD patients over the 15-year observation period, particularly in individuals with moderate and severe CHD when compared with the general population. Thus, life-long special care is required for all surgically corrected or palliated ACHD patients. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-03-01 2022 /pmc/articles/PMC9334441/ /pubmed/35229166 http://dx.doi.org/10.1007/s00392-022-01989-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Müller, Matthias J. Norozi, Kambiz Caroline, Jonas Sedlak, Nicole Bock, Jonas Paul, Thomas Geyer, Siegfried Dellas, Claudia Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title | Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title_full | Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title_fullStr | Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title_full_unstemmed | Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title_short | Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
title_sort | morbidity and mortality in adults with congenital heart defects in the third and fourth life decade |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334441/ https://www.ncbi.nlm.nih.gov/pubmed/35229166 http://dx.doi.org/10.1007/s00392-022-01989-1 |
work_keys_str_mv | AT mullermatthiasj morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT norozikambiz morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT carolinejonas morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT sedlaknicole morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT bockjonas morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT paulthomas morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT geyersiegfried morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade AT dellasclaudia morbidityandmortalityinadultswithcongenitalheartdefectsinthethirdandfourthlifedecade |